← Human Trials & Peer-Reviewed Studies
Oral zinc supplements are ineffective for treating acute dehydrating diarrhoea in 5-12-year-olds.
Plain-language guide to PMID 24673165 (2015): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 24673165
- Journal
- Acta paediatrica (Oslo, Norway : 1992)
- Year
- 2015
- Study type
- Randomized Controlled Trial
- Authors
- Negi R et al. (6 authors)
- DOI
- 10.1111/apa.12645
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
Many countries have guidelines recommending the use of oral zinc in acute dehydrating diarrhoea in children aged 2 months to 5 years of age, but no guidelines exist for older children.
Who Took Part
The age groups tagged for this paper are young children and children, both men and women.
How the Study Was Run
The design is described as randomized, double-blind and placebo-controlled.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
Blinding on both sides kept the participants and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.
Some participants received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.
The primary outcome variable was the time taken for diarrhoea to stop.
Secondary outcome variables included time taken for rehydration, duration of hospitalisation and recurrence of diarrhoea in the next 3 months.
What Was Measured
Topics PubMed links to this paper include Acute Disease, Dehydration, Diarrhea, Dietary Supplements, Patient Admission, Treatment Failure and Zinc.
Author keywords: Child and Diarrhoea.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.
Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2015 (Acta paediatrica (Oslo, Norway : 1992)), a journal based in Norway.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.